CN112903838A - 法维拉韦中有关物质的测定方法 - Google Patents
法维拉韦中有关物质的测定方法 Download PDFInfo
- Publication number
- CN112903838A CN112903838A CN202110052136.7A CN202110052136A CN112903838A CN 112903838 A CN112903838 A CN 112903838A CN 202110052136 A CN202110052136 A CN 202110052136A CN 112903838 A CN112903838 A CN 112903838A
- Authority
- CN
- China
- Prior art keywords
- faviravir
- impurity
- solution
- mobile phase
- related substances
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/74—Optical detectors
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
时间(分钟) | 流动相A(%) | 流动相B(%) |
0 | 100 | 0 |
3 | 100 | 0 |
25 | 80 | 20 |
35 | 80 | 20 |
35.01 | 100 | 0 |
45 | 100 | 0 |
法维拉韦片 | 已知杂质A | 其他单个杂质1 | 总杂质 |
结果 | 0.13% | 0.05% | 0.18% |
时间(分钟) | 流动相A(%) | 流动相B(%) |
0 | 100 | 0 |
3 | 100 | 0 |
25 | 80 | 20 |
35 | 80 | 20 |
35.01 | 100 | 0 |
45 | 100 | 0 |
法维拉韦 | 已知杂质A | 其他单个杂质1 | 总杂质 |
结果 | 0.00% | 0.05% | 0.05% |
Claims (6)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110052136.7A CN112903838A (zh) | 2021-01-15 | 2021-01-15 | 法维拉韦中有关物质的测定方法 |
PCT/CN2021/133028 WO2022151841A1 (zh) | 2021-01-15 | 2021-11-25 | 法维拉韦中有关物质的测定方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110052136.7A CN112903838A (zh) | 2021-01-15 | 2021-01-15 | 法维拉韦中有关物质的测定方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112903838A true CN112903838A (zh) | 2021-06-04 |
Family
ID=76113297
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110052136.7A Pending CN112903838A (zh) | 2021-01-15 | 2021-01-15 | 法维拉韦中有关物质的测定方法 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN112903838A (zh) |
WO (1) | WO2022151841A1 (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113413365A (zh) * | 2021-07-30 | 2021-09-21 | 合肥医工医药股份有限公司 | 一种稳定的法维拉韦口服溶液制剂及其制备方法 |
WO2022151841A1 (zh) * | 2021-01-15 | 2022-07-21 | 浙江海正药业股份有限公司 | 法维拉韦中有关物质的测定方法 |
CN115494184A (zh) * | 2022-05-09 | 2022-12-20 | 浙江海正药业股份有限公司 | 一种同时检测药物中异丙苯磺酸甲酯、异丙苯磺酸乙酯的方法 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117092254B (zh) * | 2023-10-18 | 2024-01-26 | 吉林四环制药有限公司 | 氨基己酸或其制剂中杂质的检测方法 |
CN117647607B (zh) * | 2024-01-30 | 2024-04-26 | 山东百诺医药股份有限公司 | 一种同时测定5-(2-氟苯基)-1h-吡咯-3-甲醛中有关物质的hplc检测方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104914185A (zh) * | 2015-06-10 | 2015-09-16 | 山东省药学科学院 | 一种法匹拉韦中有关物质的hplc测定方法 |
CN111228226A (zh) * | 2020-03-06 | 2020-06-05 | 瑞阳制药有限公司 | 一种供注射用法匹拉韦的冻干制剂及其制备方法 |
WO2020194042A1 (en) * | 2019-03-22 | 2020-10-01 | Shionogi & Co., Ltd. | Treating influenza using substituted polycyclic pyridone derivatives and prodrugs thereof in a subject having influenza and a severe influenza condition |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080206883A1 (en) * | 2007-02-26 | 2008-08-28 | Cody Laboratories, Inc. | Hplc method for separation and detection of hydromorphone and related opioid pharmacophores |
CN104678006B (zh) * | 2014-09-25 | 2016-06-01 | 广东东阳光药业有限公司 | 一种苹果酸舒尼替尼有关物质分析方法 |
CN112213418B (zh) * | 2020-09-17 | 2022-08-23 | 石家庄凯瑞德医药科技发展有限公司 | 索非布韦中有关物质的检测方法 |
CN112903838A (zh) * | 2021-01-15 | 2021-06-04 | 浙江海正药业股份有限公司 | 法维拉韦中有关物质的测定方法 |
-
2021
- 2021-01-15 CN CN202110052136.7A patent/CN112903838A/zh active Pending
- 2021-11-25 WO PCT/CN2021/133028 patent/WO2022151841A1/zh active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104914185A (zh) * | 2015-06-10 | 2015-09-16 | 山东省药学科学院 | 一种法匹拉韦中有关物质的hplc测定方法 |
WO2020194042A1 (en) * | 2019-03-22 | 2020-10-01 | Shionogi & Co., Ltd. | Treating influenza using substituted polycyclic pyridone derivatives and prodrugs thereof in a subject having influenza and a severe influenza condition |
CN111228226A (zh) * | 2020-03-06 | 2020-06-05 | 瑞阳制药有限公司 | 一种供注射用法匹拉韦的冻干制剂及其制备方法 |
Non-Patent Citations (5)
Title |
---|
İBRAHIM BULDUK: "HPLC-UV method for quantification of favipiravir in pharmaceutical formulations", 《ACTA CHROMATOGRAPHICA》 * |
刘葵葵 等: "法匹拉韦中有关物质的HPLC法测定", 《中国药师》 * |
张涛: "抗流感病毒药物法匹拉韦的产业化与奥司他韦"Me-Too"药物的研究", 《中国优秀博硕士学位论文全文数据库(博士)工程科技Ⅰ辑》 * |
柳文媛 等: "《药物分析进展 第二版》", 30 September 2018, 江苏凤凰科学技术出版社 * |
邓玉晓 等: "抗流感药法匹拉韦杂质的合成", 《食品与药品》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022151841A1 (zh) * | 2021-01-15 | 2022-07-21 | 浙江海正药业股份有限公司 | 法维拉韦中有关物质的测定方法 |
CN113413365A (zh) * | 2021-07-30 | 2021-09-21 | 合肥医工医药股份有限公司 | 一种稳定的法维拉韦口服溶液制剂及其制备方法 |
CN113413365B (zh) * | 2021-07-30 | 2022-11-22 | 合肥医工医药股份有限公司 | 一种稳定的法维拉韦口服溶液制剂及其制备方法 |
CN115494184A (zh) * | 2022-05-09 | 2022-12-20 | 浙江海正药业股份有限公司 | 一种同时检测药物中异丙苯磺酸甲酯、异丙苯磺酸乙酯的方法 |
Also Published As
Publication number | Publication date |
---|---|
WO2022151841A1 (zh) | 2022-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112903838A (zh) | 法维拉韦中有关物质的测定方法 | |
WO2022062961A1 (zh) | 一种检测依折麦布辛伐他汀片中6-氧代辛伐他汀含量的方法 | |
CN115097023A (zh) | 佐米胺有关物质的高效液相色谱检测方法 | |
CN113866337B (zh) | 一种分离与测定磷酸奥司他韦同分异构体的质量分析方法 | |
CN110068623B (zh) | 一种咪达那新中有关物质的检测方法 | |
Mihaljica et al. | Determination of lercanidipine hydrochloride and its impurities in tablets | |
Ghosh et al. | Development of stability indicating RP-HPLC method and validation for the estimation of vilazodone hydrochloride | |
CN110687223B (zh) | 一种丙戊酸钠原料乙酰乙酸甲酯的含量测定方法 | |
CN103926350A (zh) | 康复新液制剂指纹图谱的检查方法及标准指纹图谱 | |
CN114994205B (zh) | 地拉罗司颗粒剂中相关杂质的检测方法 | |
CN114264765B (zh) | 一种利用hplc测定格列美脲中间体中有关物质的分析方法 | |
CN114689737A (zh) | 一种s-邻氯苯甘氨酸甲酯酒石酸盐有关物质的分析方法 | |
GA et al. | VALIDATED RP-HPLC AND UV-SPECTROSCOPY METHODS FOR THE ESTIMATION OF DAPAGLIFLOZIN IN BULK AND IN TABLETS. | |
CN114965790B (zh) | 一种赖氨葡锌颗粒中氨基酸杂质的液相检测方法 | |
CN115236255B (zh) | 一种洛索洛芬钠有关物质检测方法 | |
CN114324665B (zh) | 一种阿德福韦酯片致突变杂质的检测方法 | |
Vinukonda | Determination of Irinotecan enantiomer impurity in Irinotecan Hydrochloride API by using reverse-phase liquid chromatography | |
CN112611819B (zh) | 一种苯磷硫胺原料及其制剂中有关物质的测定方法 | |
CN112816609B (zh) | 一种在制剂生产过程中检测磷酸肌酸钠残留的方法 | |
CN113125626B (zh) | 一种从左乙拉西坦口服液中检测右旋异构体的hplc方法 | |
CN115840008A (zh) | 一种盐酸乌拉地尔原料药中基因毒性杂质的测定方法 | |
CN117949552A (zh) | 一种替米沙坦有关物质的检测方法 | |
CN118067860A (zh) | 一种依帕司他片中有关物质的检测方法 | |
Srikanth et al. | Method Development and Validation for Quantitative Estimation of Bortezomib in its Bulk and Pharmaceutical Formulation | |
CN117871737A (zh) | 一种腺苷注射液的检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Hongjie Inventor after: Chen Xiaoyan Inventor after: Du Jiaqiu Inventor after: Tan Yi Inventor after: Gao Hua Inventor after: Yang Zhiqing Inventor after: Chen Lei Inventor before: Li Hongjie Inventor before: Chen Xiaoyan Inventor before: Tan Yi Inventor before: Gao Hua |
|
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20210604 |